FDA Inspection 1245934 — Xytex Laboratories

Xytex Laboratories — FEI 3017451050

The FDA completed an inspection of Xytex Laboratories on Jul 25, 2024 in Marietta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 25, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Marietta, GA (United States)